(Press-News.org) AMHERST, Mass. – Recently, large studies have identified some of the genetic basis for important common diseases such as heart disease and diabetes, but most of the genetic contribution to them remains undiscovered. Now researchers at the University of Massachusetts Amherst led by biostatistician Andrea Foulkes have applied sophisticated statistical tools to existing large databases to reveal substantial new information about genes that cause such conditions as high cholesterol linked to heart disease.
Foulkes says, "This new approach to data analysis provides opportunities for developing new treatments. It also advances approaches to identifying people at greatest risk for heart disease. Another important point is that our method is straightforward to use with freely available computer software and can be applied broadly to advance genetic knowledge of many diseases. We hope this moves us toward greater understanding of common disorders and improving overall health in our society."
The new analytical approach she developed with cardiologist Dr. Muredach Reilly at the University of Pennsylvania and others is called "Mixed modeling of Meta-Analysis P-values" or MixMAP. Because it makes use of existing public databases, the powerful new method represents a low-cost tool for investigators.
Foulkes, who directs the Institute for Computational Biology, Biostatistics and Bioinformatics at UMass Amherst, explains that MixMAP draws on a principled statistical modeling framework and the vast array of summary data now available from genetic association studies to formally test at a new, locus-level, association. Other members of the team at UMass Amherst are Rongheng Lin, an assistant professor, and postdoctoral researchers Gregory Matthews and Ujwall Das.
The new method, which is generalizable to other problems, takes into account the structure of the genome, Foulkes explains. In genetic epidemiology, traditional genome-wide association studies look at common genetic variations in a group of people with a disease compared to healthy controls, focusing on single-nucleotide polymorphisms (SNP) to see if any single variant is associated with that disease. If one variant is found more often in people with the disease, the SNP is thought to be associated with it.
While that traditional statistical method looks for one unusual "needle in a haystack" as a possible disease signal, Foulkes and colleagues' new method uses knowledge of DNA regions in the genome that are likely to contain several genetic signals for disease variation clumped together in one region. Thus, it is able to detect groups of unusual variants rather than just single SNPs, offering a way to "call out" gene regions that have a consistent signal above normal variation.
Foulkes offers a non-technical analogy, "It's like listening to an orchestra. If there is one drum, we all hear it, and we hear the cello section even if each instrument is playing quietly, because they are all playing together. Current statistical methods can hear the drum, but not the cellos, no matter how many are playing, because no single cello is as loud as the drum. Our method can do this, which adds considerable statistical strength to our ability to identify new genes that may be associated with disease."
Reilly points out that as a complementary strategy to traditional methods, MixMAP will be of great interest to the statistical and cardiovascular genomics community. It can be applied to existing genetic studies of blood cholesterol levels and it already suggests a dozen new genes to explore further for an important heart disease risk factor: Low density lipoprotein cholesterol.
Foulkes characterizes the new technique as discovery science still in need of validation, but it's discovery science that goes farther than usual by using sophisticated modeling approaches to quantify error. "We've done better than simply identify the strongest signals, we've quantified measures of association to show they are statistically meaningful," she points out.
Overall, the authors say, "MixMAP offers new and complementary information as compared to single nucleotide polymorphism-based analysis approaches and is straightforward to implement with existing open-source statistical software tools."
INFORMATION:
This work was supported by the National Institutes of Health National Heart, Lung and Blood Institute.
END
A team led by Vanderbilt University investigators has discovered two new genes – both coding for the signaling protein calmodulin – associated with severe early-onset disorders of heart rhythm. The findings, reported online Feb. 6 in the journal Circulation, expand the list of culprits that can cause sudden cardiac death and may point to new therapeutic approaches.
Nearly two decades of research have identified more than 25 genes in which mutations can increase risk for life-threatening cardiac arrhythmias, said Alfred George, Jr., M.D., chief of the Division of Genetic ...
MINNEAPOLIS/SAINT PAUL (February 6, 2013) – Researchers at the University of Minnesota have uncovered a human enzyme responsible for causing DNA mutations found in the majority of breast cancers. The discovery of this enzyme – called APOBEC3B – may change the way breast cancer is diagnosed and treated.
The findings from a team of researchers led by Reuben Harris, Ph.D., associate professor of biochemistry, molecular biology and biophysics and also a researcher at the Masonic Cancer Center, University of Minnesota, are published in the latest edition of Nature.
"We ...
WASHINGTON, DC – Despite dire predictions in the wake of the economic crisis, donations to health projects in developing countries appear to be holding steady, according to new research from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
After reaching a historic high of $28.2 billion in 2010, development assistance for health dropped in 2011 and recovered in 2012. The strong growth in spending from the GAVI Alliance and UNICEF counterbalanced declines in health spending among other donors.
The new findings are being announced ...
An automated supernova hunt is shedding new light on the death sequence of massive stars—specifically, the kind that self-destruct in Type IIn supernova explosions.
Digging through the Palomar Transient Factory (PTF) data archive housed at the Department of Energy's National Energy Research Scientific Computing Center (NERSC) at Lawrence Berkeley National Laboratory (Berkeley Lab), astronomers have found the first causal evidence that these massive stars shed huge amounts of material in a "penultimate outburst" before final detonation as supernovae.
A focused search ...
The climate is getting warmer, and sea levels are rising – a threat to island nations. As a group of researchers lead by colleagues from the University of Bonn found out, at the same time, tiny single-cell organisms are spreading rapidly through the world's oceans, where they might be able to mitigate the consequences of climate change. Foraminifera of the variety Amphistegina are stabilizing coastlines and reefs with their calcareous shells. The study's results have now appeared in the international online journal "PLOS ONE."
Countless billions of tiny, microscopic ...
Pasadena, CA—Type II supernovae are formed when massive stars collapse, initiating giant explosions. It is thought that stars emit a burst of mass as a precursor to the supernova explosion. If this process were better understood, it could be used to predict and study supernova events in their earliest stages. New observations from a team of astronomers including Carnegie's Mansi Kasliwal show a remarkable mass-loss event about a month before the explosion of a type IIn supernova. Their work is published on February 7 in Nature.
Several models for the supernova-creation ...
TORONTO, Feb. 6, 2013—A popular class of drugs commonly used to treat sleep and mood symptoms continues to be frequently prescribed despite being known to have potentially life-threatening side effects.
Previous studies have linked benzodiazepines – a medication class that may be used in chronic obstructive pulmonary disease (COPD) to treat symptoms of insomnia, depression, anxiety and shortness of breath – with adverse outcomes, but until now there has been little information on how frequently it's prescribed or who is using it.
COPD, also known as emphysema or chronic ...
LIBREVILLE, GABON (February 6, 2013): The Wildlife Conservation Society (WCS) announced today that a national park, once home to Africa's largest forest elephant population, has lost a staggering 11,100 individuals due to poaching for the ivory trade.
The shocking figures come from Gabon's Minkebe Park, where recent surveys of areas within the park revealed that two thirds of its elephants have vanished since 2004. The majority of these losses have probably taken place in the last five years.
Gabon contains over half of Africa's forest elephants, with a population estimated ...
Until a child's bones have fully matured (in girls, typically by age 14; in boys, age 16), an injury to the anterior cruciate ligament (ACL)—the primary, stabilizing ligament of the knee joint—requires special consideration, treatment and care to ensure appropriate healing and to prevent long-term complications.
According to a review article in the February 2013 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), ACL injuries once were considered rare in children and adolescents. However, the number of ACL injuries in young athletes is on the ...
A young woman in Tokyo pays 243,000 Yen for a Louis Vuitton suitcase emblazoned with the company's iconic monogram. A continent away, another woman purchases the same suitcase at the company's store on New York's 5th Avenue for the equivalent price in dollars, $3000. Why? What motivates their purchases? And, do those motivations hinge on their location?
That is precisely what Professor Jaehee Jung and her collaborators at universities in 9 other countries sought to answer. Their findings published recently in the journal, Psychology & Marketing, compared consumers' ...
